Senseonics gets approval for new CGM device

Words
54
Reading
1 min
Listen
Play
8y

Senseonics have got approval from the FDA for their new continuous glucose monitor “eversense”.

3EDC8058-78DE-422C-A708-42425215E0FD.png

The sensor is implanted into the arm under local anaesthetic, and supposed to last for up to 90 days compared to current sensors which only last for up to two weeks. For more information you can check out their website

Senseonics gets approval for new CGM device | Ecency